Gurugram: Fortis Healthcare reported a 17.3 per cent year on year (YoY) growth in consolidated revenue to Rs 2,735 crore in the three months ending September 30, 2026.
Consolidated Profit after tax after accounting for adjustments related to intercompany eliminations fell 2.5 per cent YoY to Rs 320 crore.
Revenue of Fortis’ hospital business grew 18.6 per cent YoY to Rs 2,340 crore, while PAT fell 1.1 per cent YoY to Rs 284 crore.
Occupancy rose slightly to 72 per cent in Q2 FY27 from 71 per cent last year.
ARPP increased to Rs 2.10 lakh from Rs 1.96 lakh, and the average length of stay edged up to 4.20 days from 4.18 days.
Revenue growth in the hospital business for the quarter was led by an approximately 7% increase in ARPP and an increase of approximately 9% in occupied beds compared to Q2 FY26, Fortis said.
Its diagnostics arm saw a 12.2 per cent YoY increase in revenue to Rs 448 crore, and PAT increased 15.8 per cent YoY to Rs 68 crore.
For the 6 months ended September, consolidated revenue grew 17.4 per cent YoY to Rs 5,280 crore and PAT fell 0.4 per cent to Rs 593 crore.
Dr Ashutosh Raghuvanshi, MD and CEO, Fortis Healthcare stated, “We have witnessed another quarter of sustained growth, maintaining our growth trajectory in Q2 FY27 across our hospital and diagnostics businesses. We remain committed to strengthening our clinical capabilities and expanding our presence in key markets. We advanced our network expansion strategy recently through the acquisition of 110 bedded Suguna Hospital in Bengaluru taking the total number of operational beds in the region to approx. 1,000 beds. We also entered into a long-term healthcare services agreement for a 400+ bedded super-specialty hospital in Ashok Vihar, New Delhi. Both these growth initiatives will further strengthen our presence in the Bengaluru and Delhi NCR clusters respectively and support our long-term growth ambitions.”
He added, “Our diagnostics business continued to demonstrate consistent growth and strong operational momentum. With our ongoing capacity expansion initiatives, focus on clinical excellence and disciplined execution of our growth strategy, we remain well positioned to capitalise on the growing demand for quality healthcare services in India and deliver sustainable growth over the coming years.”
